非酒精性脂肪性肝炎美国肝脏病学会专题研讨会纪要

::200080200292022(NASH),25NASH1980LudwigNASH,NASH,NASH,,,,,140g5%10%,(NAFL)(NAFLD),NAFLD,,,NAFL;,NAFLD,NAFLDNASH,NAFLD4:1,;2,1;3,2;4,3Mallory1,34NASH,2,(BMI)NASH:()(/)(3)3,,NASH;NASH;,NASH,NASH3;,NASH14,4NASHNASH,NASH,80%NASH,,NASH,,NASH,NAFLD20%30%,10%2%3%NASH,1/3NASH(60%)NASH(20%25%)(2%3%)NAFLD/NASH,NASH70%,NAFL1%2%,60%,(IR)NAFLD,1/4,IRNASH,1NASH,NAFLDIR,NAFLDIR,NAFLD,,(4050)()NAFLDNASH,ASTALTIgANASH,AST/ALT1,,NAFLD,,,NASH51067%59%,,,NAFLD,,34NAFLD525%15%2NAFLD,1NAFLD,9520036821NASH()(,)()BMI()/()(,Weber2Christian)()()ASTALT,1.5ULN,10ULNALTAST,GGTALP(1/3)(20%25%,)IgA(25%,IgA)(ANA)(33%)()BCTMRI25%30%(),NASH,NAFLD,NAFLDMalloryNAFLD,IRP4502E1(CYP2E1)(FFA),NASHNAFLD1NAFLDIR,NAFLD,NASH,,IR,,,IRNAFLDIR,FFA(TNF)IRNASH(leptin)ob/obfa/faIR,NASHNAFLD196735NAFLD/NASH,E(10),,,IR,BMIATP,NAFLD()NAFLD(20g/d),NASH,,,()1/3,NAFLD/NASHBMI,,IR,,,,1.6kg(),,()IR,,,NASHNAFLD,()NAFLD,NAFLDNAFLD06ChineseHepatology,June2003,Vol8,No.2(),NASH,,NASH()ES2N2,ENASH,ENAFLD,lazaroidsNASHNASH,(),IR,NASH,,(2)()IRNAFLD(),NASH,,2,NASHNASH7NASHatorvastatin21,,13NASH,,NAFLDNAFLD(),NAFLD,NASHNASH,,NASHNASH,NASH,,()NAFLD?NAFLD,NAFLD?IR?NAFLD?IRNAFLD?()NAFLD?NAFLD?NAFLDANAIgA?NAFLD?IR?NASH?NAFLD?NASH?,IRNAFLD?(),,,?NAFLDIR,,?,,?NAFLDIR?FFANAFLDIR?NAFLD?NASH,?()IRNAFLD??NAFLD?1NAFLD(:2003204215)162003682